MAPK/ERK KINASE INHIBITOREN

Patent europeic · EP2150544 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2150544
Numer da la dumonda
EP08732372
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
17-03-2008
Publitgà
10-02-2010
Concedì
13-01-2016
La protecziun finescha il pli tard
16-03-2028
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C07D 401/12 (2006.01)
C07D 215/56 (2006.01)
C07D 215/38 (2006.01)
C07D 491/052 (2006.01)
Prioritad
US 895617 P 19.03.2007
Dumonda PCT
PCT/US2008/057276 17.03.2008
Publicaziun PCT
WO2008/115890 25.09.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 13-01-2016

    Concedì

    Published in Swissreg on 13.01.2016

Partidas

Possessur

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP

Inventur

DONG, Qing

San Diego, CA 92130, US

KANOUNI, Toufike

San Diego, CA 92121, US

WALLACE, Michael B.

San Diego, CA 92117, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.